Canada Markets closed

Appili Therapeutics Inc. (APLI.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.07000.0000 (0.00%)
At close: 11:50AM EDT
Full screen
Previous Close0.0700
Open0.0675
Bid0.0650 x N/A
Ask0.0700 x N/A
Day's Range0.0675 - 0.0700
52 Week Range0.0550 - 1.1400
Volume13,812
Avg. Volume163,318
Market Cap4.989M
Beta (5Y Monthly)0.93
PE Ratio (TTM)N/A
EPS (TTM)-0.4440
Earnings DateFeb 10, 2022 - Feb 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.43
  • Business Wire

    Appili Therapeutics to Present at WorldLeish7 Conference in Cartagena, Columbia

    HALIFAX, Nova Scotia, August 02, 2022--Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that Armand Balboni, M.D, Ph.D, Chief Executive Officer, and Yoav Golan, M.D, Chief Medical Officer of Appili, will participate at the seventh iteration of WorldLeish, from August 1 to 6 2022, and present an update on Appili program ATI-1801.

  • Baystreet

    Stocks in play: Appili Therapeutics Inc.

    Announced its financial and operational results for the fiscal year ended March 31, 2022. The net loss ...

  • Business Wire

    Appili Therapeutics Reports Fiscal Year 2022 Financial and Operational Results

    HALIFAX, Nova Scotia, June 29, 2022--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced its financial and operational results for the fiscal year ended March 31, 2022, and provided an update on the Company’s strategy for fiscal 2023. All figures are stated in Canadian dollars unless otherwise stated.